Horan Securities’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $460K | Buy |
5,812
+301
| +5% | +$23.9K | 0.16% | 80 |
|
|
2025
Q1 | $495K | Sell |
5,511
-927
| -14% | -$86.5K | 0.19% | 61 |
|
|
2024
Q4 | $640K | Buy |
6,438
+5
| +0.1% | +$515 | 0.24% | 46 |
|
|
2024
Q3 | $731K | Buy |
6,433
+2,332
| +57% | +$277K | 0.28% | 42 |
|
|
2024
Q2 | $508K | Buy |
4,101
+4
| +0.1% | +$515 | 0.22% | 46 |
|
|
2024
Q1 | $541K | Buy |
4,097
+165
| +4% | +$20.3K | 0.26% | 39 |
|
|
2023
Q4 | $429K | Buy |
3,932
+26
| +0.7% | +$2.7K | 0.22% | 48 |
|
|
2023
Q3 | $402K | Sell |
3,906
-41
| -1% | -$4.42K | 0.21% | 51 |
|
|
2023
Q2 | $455K | Buy |
3,947
+70
| +2% | +$7.95K | 0.19% | 58 |
|
|
2023
Q1 | $412K | Buy |
3,877
+196
| +5% | +$21.2K | 0.21% | 51 |
|
|
2022
Q4 | $408K | Buy |
3,681
+312
| +9% | +$31.9K | 0.23% | 43 |
|
|
2022
Q3 | $290K | Buy |
3,369
+56
| +2% | +$5K | 0.18% | 55 |
|
|
2022
Q2 | $312K | Buy |
3,313
+189
| +6% | +$16.8K | 0.19% | 50 |
|
|
2022
Q1 | $256K | Buy |
3,124
+171
| +6% | +$13.5K | 0.15% | 64 |
|
|
2021
Q4 | $226K | Buy |
+2,953
| New | +$235K | 0.13% | 73 |
|
|
2021
Q2 | $156K | Buy |
2,008
+1,017
| +103% | +$75.6K | 0.11% | 88 |
|
|
2021
Q1 | $73K | Buy |
991
+445
| +82% | +$32.8K | 0.06% | 111 |
|
|
2020
Q4 | $43K | Buy |
546
+254
| +87% | +$19.4K | 0.04% | 134 |
|
|
2020
Q3 | $23K | Buy |
292
+156
| +115% | +$12.2K | 0.02% | 155 |
|
|
2020
Q2 | $10K | Buy |
136
+15
| +12% | +$1.13K | 0.01% | 178 |
|
|
2020
Q1 | $9K | Buy |
+121
| New | +$9.51K | 0.01% | 138 |
|
|
2019
Q4 | – | Sell |
-121
| Closed | -$10K | – | 157 |
|
|
2019
Q3 | $10K | Hold |
121
| – | – | 0.01% | 161 |
|
|
2019
Q2 | $10K | Sell |
121
-105
| -46% | -$8.04K | 0.01% | 175 |
|
|
2019
Q1 | $18K | Hold |
226
| – | – | 0.02% | 116 |
|
|
2018
Q4 | $16K | Hold |
226
| – | – | 0.02% | 116 |
|
|
2018
Q3 | $16K | Hold |
226
| – | – | 0.02% | 99 |
|
|
2018
Q2 | $14K | Buy |
226
+105
| +87% | +$5.92K | 0.01% | 109 |
|
|
2018
Q1 | $7K | Hold |
121
| – | – | 0.01% | 132 |
|
|
2017
Q4 | $7K | Hold |
121
| – | – | 0.01% | 134 |
|
|
2017
Q3 | $7K | Hold |
121
| – | – | 0.01% | 124 |
|
|
2017
Q2 | $7K | Hold |
121
| – | – | 0.01% | 117 |
|
|
2017
Q1 | $7K | Buy |
+121
| New | +$7.34K | 0.01% | 114 |
|
|
2016
Q4 | – | Sell |
-121
| Closed | -$7K | – | 107 |
|
|
2016
Q3 | $7K | Buy |
+121
| New | +$7.08K | 0.01% | 98 |
|
Other funds holding MRK
Horan Securities's MRK Position: Q2 2025 in Review
Horan Securities increased its Merck (MRK) stake by 5.5% in Q2 2025, buying an estimated $23.9K and bringing the position to 5,812 shares worth $460K. The position accounts for 0.16% of the portfolio, ranked #80.
Horan Securities first reported a position in MRK in Q3 2016 and has held it in 33 quarters since. The position peaked at $731K in Q3 2024. 3,327 funds tracked by Wall St. Rank hold MRK as of Q2 2025.
- Horan Securities held 5,812 shares of Merck worth $460K as of Q2 2025.
- Horan Securities bought 301 Merck shares in Q2 2025, an estimated $23.9K.
- Merck made up 0.16% of Horan Securities's portfolio in Q2 2025, its #80 holding.
- Horan Securities first reported a position in Merck in Q3 2016 and has held it in 33 quarters since.
- Horan Securities's Merck position peaked at $731K in Q3 2024.
- 3,327 funds tracked by Wall St. Rank held Merck as of Q2 2025.
Based on Horan Securities's 13F filing for Q2 2025, filed 6 Aug 2025.